135 related articles for article (PubMed ID: 34016716)
1. Soluble type immune checkpoint regulators using multiplex luminex immunoassay in chronic hepatitis B patients.
Fadriquela A; Kim CS; Lee KJ; Kang SH; Kim MY; Lee JH
J Clin Pathol; 2021 Dec; 74(12):780-786. PubMed ID: 34016716
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis.
Li W; Xia Y; Yang J; Guo H; Sun G; Sanyal AJ; Shah VH; Lou Y; Zheng X; Chalasani N; Yu Q
Hepatol Commun; 2020 Apr; 4(4):588-605. PubMed ID: 32258953
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection.
Lee N; Jeong S; Jeon K; Park MJ; Song W
Front Immunol; 2022; 13():903419. PubMed ID: 36045684
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of immune checkpoint regulators and potential role of soluble TIM-3 and LAG-3 in male patients with alcohol-associated liver disease.
Fadriquela A; Kim CS; Lee KJ; Kang SH; Lee JH
Alcohol; 2022 Feb; 98():9-17. PubMed ID: 34695559
[TBL] [Abstract][Full Text] [Related]
6. Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B.
Zhou L; Li X; Huang X; Chen L; Gu L; Huang Y
J Viral Hepat; 2019 Jul; 26(7):795-802. PubMed ID: 30578715
[TBL] [Abstract][Full Text] [Related]
7. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study.
Zeng LY; Lian JS; Chen JY; Jia HY; Zhang YM; Xiang DR; Yu L; Hu JH; Lu YF; Zheng L; Li LJ; Yang YD
World J Gastroenterol; 2014 Jul; 20(27):9178-84. PubMed ID: 25083092
[TBL] [Abstract][Full Text] [Related]
9. Expression of programmed death ligand 1 in drug-resistant osteosarcoma: An exploratory study.
Skertich NJ; Chu F; Tarhoni IA; Szajek S; Borgia JA; Madonna MB
Surg Open Sci; 2021 Oct; 6():10-14. PubMed ID: 34386763
[TBL] [Abstract][Full Text] [Related]
10. Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are associated with chronic hepatitis B virus (HBV) infection.
Zhao Z; Liu J; Wang J; Xie T; Zhang Q; Feng S; Deng H; Zhong B
Int Immunopharmacol; 2017 Oct; 51():1-8. PubMed ID: 28759808
[TBL] [Abstract][Full Text] [Related]
11. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
12. Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B.
Chen Y; Huang Z; Ma D; Chen L; Lai Q; Huang X; Zhou J; Zhang X; Ma Q; Chen Z; Zuo D
BMC Immunol; 2015 May; 16():29. PubMed ID: 25982058
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection.
Wongjitrat C; Sukwit S; Chuenchitra T; Seangjaruk P; Rojanasang P; Romputtan P; Srisurapanon S
J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S54-9. PubMed ID: 23724456
[TBL] [Abstract][Full Text] [Related]
14. Serum decoy receptor 3 is a useful predictor for the active status of chronic hepatitis B in hepatitis B e antigen-negative patients.
Hou Y; Xu P; Lou X; Liang D; Zhang M; Zhang Z; Zhang L
Tohoku J Exp Med; 2013 Aug; 230(4):227-32. PubMed ID: 23925044
[TBL] [Abstract][Full Text] [Related]
15. Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure.
Liang XS; Li CZ; Zhou Y; Yin W; Liu YY; Fan WH
World J Gastroenterol; 2014 Jul; 20(26):8558-71. PubMed ID: 25024610
[TBL] [Abstract][Full Text] [Related]
16. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
[TBL] [Abstract][Full Text] [Related]
17. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
18. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
[TBL] [Abstract][Full Text] [Related]
19. Serum soluble urokinase-type plasminogen activator receptor and interferon-γ-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B.
Sevgi DY; Bayraktar B; Gündüz A; Özgüven BY; Togay A; Bulut E; Uzun N; Dökmetaş İ
Wien Klin Wochenschr; 2016 Jan; 128(1-2):28-33. PubMed ID: 26546355
[TBL] [Abstract][Full Text] [Related]
20. Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients.
Diang XC; Ma LN; Li YF; Liu XY; Zhang X; Liu JY; Sheng YJ; Zhang DZ; Hu HD; Ren H
Hepatogastroenterology; 2012; 59(120):2357-60. PubMed ID: 22688015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
